Thank you for submitting your manuscript for consideration by The EMBO Journal. Three referees have now evaluated it, and their comments are shown below. As you will see the referees are generally very positive and would support publication here after appropriate revision. I would thus like to invite you to submit a revised version of the manuscript in which the referees' concerns are addressed in an adequate manner and to their full satisfaction. I should add that it is EMBO Journal policy to allow only a single round of revision and that acceptance will therefore depend on the completeness of your responses in the revised version of the manuscript.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Peer Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as standard revision time. As a matter of policy, competing manuscripts published during this period will not negatively impact on our assessment of the conceptual advance presented by your study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed.
Please to not hesitate to contact me at any time in case you wish to discuss any aspect of the revision further.
Thank you for the opportunity to consider your work for publication. I look forward to your revision. This paper reports an analysis of the mechanism by which extracellular polyamines potentiate the activity of NMDA subtype glutamate receptor ion channels containing the GluN2B subunit. Prior work, published over the past 12 years, has studied the effect of polyamines on NMDA receptor activity in some detail. The effects are complex, consisting of potentiation of receptor activity, modulation of affinity for the co-agonist glycine, combined with voltage-dependent channel block and an interaction with the effects of protons that also modulate (inhibit) receptor activity.
The authors use electrophysiological techniques (oocyte TEVC) in combination with genetic manipulation of the GluN1 and GluN2B subunits to perform a well-designed series of experiments that in combination suggest that for their potentiating effect, polyamines bind at a site that is formed at the interface of the NR1 and NR2 subunit amino terminal domains. In the absence of structural data the conclusions drawn are largely conjectural, and the molecular organization of the binding site(s) remains to be determined, but the results mark an important advance, which comes more than a decade after the positive allosteric actions of polyamines on NMDA receptor activity were 1st reported. The work is of interest both because of the key role these receptors play in brain function and disease, and also because a rapidly expanding body of structural data that is becoming available for this receptor family, allows for the first time the design of experiments which provide insight into molecular mechanism.
Major points 1) Figure 2 and page 6 paragraph 2. Given the interaction of the effects of polyamines and protons on NMDA receptor activity, it would be useful to discuss here and illustrate what change (if any) these deletion mutants have on pH sensitivity.
2) Figure 3c . The structure of the NR1 ATD was recently published and reported in the PDB (3Q41). The calculation should be repeated for the experimentally determined structure, and the results substituted for the homology model illustrated in panel c.
3) Figure 3d and text on page 8. The results for some these chimeras are not terribly compelling, and the least convincing section of the paper. However, this weakness is compensated later in the manuscript by independent sets of experiments reported in Figures 4 and 6.
The adage that its easy to break things in biomolecules but much harder to build novel activity raises some serious issues about whether the authors have really identified the polyamine binding site. Loss of function for the 2B-2A chimeras is not matched by the marginal spermine potentiation observed for the 2A-2B chimeras. Use of a log scale hides the issue that many of these chimeras produce much smaller extents of spermine potentiation than for wild type GluN2B. This is particularly striking for the 2A-2B (175-227) . How do the authors rationalize these results with their proposed mechanism of action?
4) The 'M2M' results initially appear compelling, but less so when it is considered that the potentiating effects are small compared to those produced by spermine. Why is this? Were other cross linkers tried. What effects does DTT and its removal have on current amplitudes for the double Cys mutants?
5) The discussion regarding the interaction between spermine and ifenprodil is interesting, and a logical outcome of all of the modelling that has lead to a model for the molecular mechanism of action of these two classes of ligand. However, in the absence of structural information directly establishing that spermine and ifenprodil bind at the proposed sites of action, such a discussion is speculative, and might well be wrong. The field is moving rapidly, and this issue is likely to be resolved soon.
Additional points
Page 5 paragraph 1 line 11: Benveniste & Mayer worked on native NMDA receptors of undefined composition expressed by neurons in cell culture, not on GluN2B.
Figure 2c: Data points for GluN2A-2B(NTD+L) are not well fit at high concentrations where channel block by polyamines is observed. As a result it is unclear how well the maximum potentiation for this mutant compares to responses for wild type. Please address.
Page 7 paragraph 1 lines 5-9: update to include NR1 ATD structure (Farina et al 2011) .
Page 11 paragraph 2 1st sentence. It would be more appropriate to cite the original paper which developed the MK801 block approach than Chen et al 1999 (I believe it is Rosenmund et al, Science 1993). 1. The authors suggest that spermine binding occurs via the bottom rim of the LL, which in NR2B is enriched in negatively charged residues mainly projecting from a beta strand, whereas allosteric transmission requires the NTD-ABD linker region (Fig. 2) . It would therefore be interesting to assess spermine potentiation of NR2B harboring the NR2A linker [NR1/NR2B-2A(L)]. In this scenario spermine binding is expected to be intact but transmission would be compromised.
2. on page 7, 1st paragraph they state that the LL interface in AMPARs is highly hydrophobic, 'solvent-buried'. This should be toned down, as this interface is not 'highly' hydrophobic, it's actually solvent accessible in GluR2 and in the case of the GluR3 subunit positive charges project into the interface (Sukumaran et al., EMBOJ 2011). 3. Since the NR1-NTD structure has been solved meanwhile (Farina et al., J. Neurosci. 2011 ), this new structure should be discussed and the NR1 homology model should be replaced in Fig. 3c . In particular the crystal structure can now be used for their electrostatic calculations.
4. Others have inicated that the positive charges in NR1 exon5 mimic polyamine binding (Traynelis et al., Science 1995) . I feel that there could be more discussion regarding the role of exon 5 in the proposed mechanism. More importantly, NR1 subunits including exon 5 (NR1-b) should be used in the recordings. It is expected that in NR1-b/NR2B heteromers the NTD cleft is locked in an open state to a greater extent, similar to NR1-a/NR2B in the presence of spermine. In this receptor tau(on) MK801 is expected to decrease and the rate of MTSPtrEA binding should increase.
5. NR2B cleft closure is (expected to be) induced by NTD ligands, such as Zn++ and ifenprodil, resulting in a lowering of the P open; cleft closure is expected to separate LLs in a dimer. A key question is to what extend negative allosteric modulation, induced by Zn++/Ifenprodil, is alleviated by spermine. This issue is mentioned briefly (Kew and Kemp 1998 reference on page 14) but warrants more in-depth treatment, at least in the discussion.
Referee #3 (Remarks to the Author):
Polyamines have soon been reported to potentiate the NMDA receptor activity. However, and despite multiple attempts based on mutagenesis studies in the late 90's, the mechanism of action of such the allosteric modulation of NMDA receptors remains unclear. Here, Mony et al. report a model that is well supported by unambiguous experimental evidence. The authors bring strong evidence that polyamines (such as spermine) act as a glue between the lower lobes of the N-terminal domain (NTD). Polyamines are shown to stabilize the dimeric interface by neutralizing the repulsive charges between clusters of negatively charged residues, then maintaining GluN2B NTD in an opencleft conformation corresponding to the active state of the NMDA receptor. Finally, the authors used their data to proposed a general model for the action of positive and negative allosteric modulators. Interestingly, the authors also demonstrate for the first time a key feature of the molecular architecture of NMDA hetero-tetramers: the NTDs of GluN1 and GluN2B are associated in a functional heterodimer.
The authors have used many different functional and biochemical approaches and molecular modeling. In many cases, they have used approaches based on both loss and gain of function strategies that provide convincing evidence supporting their interpretation. The paper is very well written, and will certainly have a major impact in the field of NMDA receptor mediated effects.
My major point is that the authors conduct their measurements at an acidic pH where the effect of polyamines is greatly amplified. This raises the interesting question of the relevance of polyamine potentiation in a physiological context. The authors should discuss the following hypotheses: is polyamine potentiation simply irrelevant to the physiology of the synapse? In some specific conditions, is the pH at the vicinity of the NMDA receptors lowered to such values that polyamine regulation becomes significant? or can polyamines counterbalance the effect of a putatively endogenous negative allosteric modulator that is present in vivo (such as Zn2+ ions) Additional specific comments:
1-Since the authors draw conclusions on the all polyamines, it would be nice if the authors could bring some data illustrating that the same can be proposed for other polyamines of different length (putrescine, cadaverine). 2-The authors did not test the effect of negative allosteric modulator (ifenprodil or zinc) on the potentiating effect by spermine. 3- Figure 2c : the linker of GluN2B seems to play an important role in the action of spermine. Can the authors provide a molecular explanation? 4- Figure 3e : Is the construct functional? 5-Introduction, page 3 : "second, allosteric modulators are generally effective at concentrations much lower than those used for ligands that compete with the natural agonist". I'm not convinced this is true. Referee #1
Major points:
1-As requested, we now show the pH sensitivity of all the chimera and deletion mutants presented in Figure 2 . For the two (NTD+L) chimera, data are taken from our previous work by Gielen et al. (Nature, 2009) . For all other constructs (R1-∆NTD, 2B-∆NTD, 2A-2BNTD, 2B-2ANTD, 2A-2BL, 2B-2AL), we performed additional experiments (full pH dose-response curves) to characterize the pH sensitivity of each construct. All the results have been unified and are now illustrated in a new figure (Supplementary Figure 1a) and discussed in the Results (p6, end of 1 st paragraph).
2-We have repeated the electrostatic calculations on the newly published GluN1 NTD crystal structure of Farina and collaborators (J. Neurosci., 2011; reference added to the reference list) and replaced our GluN1 NTD homology model accordingly ( Figure 3c and Supplementary Figure 3) .
3-It is absolutely true that the potentiation seen at GluN2A-2B(175-227) receptors is small, far from reproducing the potentiation seen at GluN2Bwt receptors. It remains, however, that with this "minichimera", we have obtained a clear gain-of-function phenotype (>3-fold potentiation at saturating spermine concentrations and at pH 6.5 vs no potentiation for GluN2Awt receptors) and we consider this result notable (gain-of-function mutants are rare and difficult to achieve!) and important for our conclusion that the b6-b8 region is key in conferring spermine binding capacity. That said, we acknowledge that the much smaller extent of spermine potentiation of the GluN2A-2B(175-227) receptors than the GluN2Bwt receptors deserves some discussion. In our previous version we had the following sentence in the Results section (p6): "These results demonstrate that the b6-b8 region of GluN2B contains key determinants involved in the GluN2B-specific spermine potentiation even if full recapitulation of GluN2B wild-type spermine sensitivity obviously requires additional determinants". In addition to this statement, we now explicitly discuss in the Discussion section (p14, end of 1 st paragraph) the fact that transferring the b6-b8 region by itself is not sufficient to match the wt spermine sensitivity and that only the "long-chimera" encompassing the whole NTD+Linker region allows a near-complete transfer. One possible explanation for this observation is that the GluN1/GluN2A NTD dimer arranges slightly differently from a GluN1/GluN2B NTD pair, thus rendering spermine binding in a GluN2A background less favourable (even though the spermine binding site per se has been transferred). This is all the more likely given that spermine binds to a site not located within a single subunit but at a labile subunit-subunit interface between a GluN1 and a GluN2B NTD.
4-The potentiating effect induced by M2M (~3-fold potentiation on GluN1-E181C/GluN2B-E201C) is in fact expected to be smaller than that of spermine (about 8-fold potentiation on wt GluN1/GluN2B receptors). This is because the M2M experiment is performed on receptors having an increased basal channel activity (compared to wt receptors), due to the introduction of the two reactive cysteine residues in GluN1 and GluN2B NTD lower lobes (mutation of the negative residues in the NTD b6-b8 region increases channel activity; see Figure 5 ). Thus, with a higher basal Po, the extent of maximal potentiation that GluN1-E181C/GluN2B-E201C receptors can experience after M2M treatment is expected to be smaller than that produced by spermine on wt receptors (assuming that both receptor types reach the same final level of channel activity after application of M2M or spermine; which is reasonable). Fully supporting this reasoning, it appears that the extent of M2M potentiation observed at GluN1-E181C/GluNB-E201C receptors closely matches the (relatively small) amplitude of spermine potentiation observed on these receptors (~2.4 fold by 200 µM spermine before M2M treatment; Figure 4d ). Yes, we have tried another cross-linker, M1M. In preliminary experiments (only 2 cells), we did observe some current potentiation with M1M but of much smaller amplitude than with M2M. We hypothesized that M1M was poorly effective at cross-linking GluN1 and GluN2B NTD lower lobes because it is too short. We decided not to continue with M1M and focused on experiments using M2M.
5-Page 14, discussion concerning the interaction between spermine and ifenprodil and their respective binding sites: we are now more cautious by explicitly stating that, at present, the sites of action of these two modulators can only be inferred from existing data, and that direct structural information will ultimately be required to identify unambiguously these sites (see modified sentence in the Discussion p15 lines 3-4).
Other points:
-We have corrected the reference list. Thank you.
- Fig 2c: yes, there is voltage-dependent channel block at high spermine concentrations and that is why we performed these DR curve experiments at -30 mV and not at -60 mV (in order to reduce the contribution of the channel block). We have now performed additional experiments to quantify the channel block. We applied voltage-ramps on currents carried by wt GluN1/GluN2B receptors both in the absence and presence of spermine (at 1 or 3 mM) and measured the ratio between the spermine potentiation observed at +50 mV (a potential at which spermine block is absent) and -30 mV. We found this ratio to be very close to 1.0 at 1 mM spermine (1.07 ± 0.006; almost no channel block) and 1.15 ± 0.01 at 3 mM spermine (n=3 cells for each condition). Thus, at 1 and 3 mM spermine, the apparent spermine potentiation observed at -30 mV is slightly smaller than at +50 mV because of the compensatory inhibitory channel block effect. To account for these effects and separate the voltage-dependent block from the (voltage-independent) spermine potentiation (the effect we are interested in), we have replotted and refitted all the spermine DR curves after adjusting the data points measured at 1 and 3 mM spermine with the above correction factors. In the revised manuscript, this procedure is described in the Methods section. As illustrated in Figure 2c , correcting for the voltage-dependent block clearly improves the quality of the fit at high spermine concentrations and allows better estimation of the maximal level of spermine potentiation. For the GluN2A-2B(NTD+L) chimera, the new value for the maximal potentiation is 11 (previously 10.5) and still matches closely that of wt GluN2B receptors (11.4; previously 10.4). These values are listed in the revised figure legend.
-Done. We now refer to Farina et al. (J. Neurosci., 2011) and the GluN1 NTD homology model presented in the paper has been replaced by the crystal structure obtained by Farina and coll.
-The citation Chen et al. (1999) has been replaced by the original paper of Rosenmund and coll. (Science, 1993).
- Figure 7 : the curve in panel d corresponding to GluN2A has been deleted. We agree that the difference between GluN2A and GluN2B reaction coordinates is very speculative. Concerning panel a and the rest of panel d, we would very much like to keep both. Indeed, regarding panel a, we believe that it is informative and useful for the general readership of the EMBO Journal to have a small cartoon depicting the molecular architecture of NMDA receptors and highlighting the arrangement of the NTD layer in respect to the ABD layer and channel pore. Nowhere else in the manuscript is the molecular organization of NMDA receptors illustrated. Concerning panel d, even if hypothetical, we strongly believe that it helps rationalize how negative and positive allosteric modulators of GluN1/GluN2B receptors can act by acting differentially on a simple 2 well-1 barrier scheme (with negative allosteric modulator stabilizing the D state by rendering exit from it energetically more costly and positive allosteric modulators like polyamines stabilizing the A state, rendering transition to the D state less favourable). We would also like to point out that an essential aspect of the model, the existence of spontaneous transitions between A and D states, derives directly from our previous work published two years ago describing the influence of NMDAR NTD conformational state on channel activity (Gielen et al. Nature, 2009 ). The fact that in the absence of any modulator the D state is represented as more stable than the A state accounts for the low maximal Po (~0.1) of GluN1/GluN2B channels.
-We have reworded the sentence (p13, 1 st sentence of the Discussion).
Referee #2
1-As requested, we have assessed the spermine sensitivity of receptors containing the chimeric GluN2B subunit in which the NTD-ABD linker has been replaced by that of GluN2A (GluN1wt/GluN2B-2A(L) receptors). By performing a full spermine dose-reponse curve, we found that these receptors display a reduced maximal level of spermine potentiation (9 fold potentiation vs 11.4 for GluN2Bwt receptors) accompanied by a modest (<2-fold) increase in spermine EC 50 (195 µM vs 127 µM for GluN2Bwt receptors). These data indicate an intact (or quasi intact) spermine binding but a reduced coupling efficacy to the downstream gating machinery. They nicely mirror the increased efficacy phenotype observed by incorporating the GluN2B linker in the GluN2A-2B(NTD) chimera (see Figure 2b) . These results are in good agreement with the proposed role for the GluN2B linker as an important structural element for the allosteric transmission that transduces spermine binding into alterations of channel activity. These (confirmatory) results obtained with GluN2B-2A(L) are now presented in the Results section (end of p6 -beginning of p7) and illustrated both in Figure 2c 4-There are indeed strong similarities between the action of polyamines on GluN2B receptors and GluN1 exon 5. We are in fact currently working on the mechanism of action of exon 5 on NMDA receptors in order to understand of how this stretch of 21 amino acids influences receptor gating. For this project, we are not only concentrating on GluN2B-containing receptors but also on receptors containing the other GluN2 subunits. Interestingly, we have observed that exon 5 has clear effects on GluN2A receptors, which is not the case for spermine (no spermine potentiating effect). There are thus interesting differences between the two "modulators". We are actively pursuing these studies (a new PhD student has recently embarked on this project) and we expect that many more months of experiments will be required to get a complete picture of exon 5 mode of action. Accordingly, our plan for the exon 5 project is to make a story on its own, separate from the present one.
5-The issue of how spermine, a positive allosteric modulator, influences the action of negative allosteric modulators such as zinc and ifenprodil is indeed an interesting one and, as noted, was only briefly discussed in our paper. We now have extended this discussion and highlight more clearly the fact that our model for NTD-based regulation of NMDA receptor activity (in which spermine binding promotes close NTD apposition while zinc or ifenprodil binding induces NTD separation) is fully compatible with and provides a mechanistic explanation for the negative interaction between negative and positive NTD-binding allosteric modulators. In particular, in addition to the results on ifenprodil by Kew and Kemp (J Physiol, 1998), we now also refer to the results obtained by Traynelis and coll. (J. Neurosci., 1998) showing that, on GluN2B receptors, spermine relieves the zinc-mediated inhibition. The expanded discussion is placed p14, last paragraph.
Referee #3
Major point: as requested, we now discuss the physiological and pathological relevance of polyamine potentiation of NMDARs. In particular, we emphasize two interesting aspects raised by the referee: i) the possibility of counterbalancing effects of polyamines and zinc ions, negative allosteric modulators of NMDARs likely to be present endogenously in physiological conditions; ii) the interplay between polyamines and extracellular pH (with spermine potentiation being magnified by elevations of extracellular acidity). Changes in extracellular pH during normal synaptic transmission have been described but these changes are usually of small amplitude (<0.1 pH unit; Chesler, Physiol. Rev., 2003) . Much larger changes have been reported, however, during pathological conditions, such as stroke or ischemia. In these conditions, pH levels of the interstitial space can fall by several tenths of a pH unit, down to value as low as 6.2 (see for instance, Silver and Erecinska, J Cereb Blood Flow Metab., 1992 and the review by Chesler and Kaila, TiNS, 1992) . These changes are large enough to strongly influence spermine potentiation of NMDA receptors (see Traynelis et al., Science 1995 and our Figure 1a) . Thus, during neuronal hyper-excitability, the concomitant release of polyamines (see Rock and MacDonald, Ann. Rev. Pharmacol. & Toxicol., 1995) with the fall of pH ext to values below 7.0 is expected to greatly magnify the extent of polyamine potentiation of NMDA receptors. Because the polyamine potentiation is specific to receptors containing the GluN2B subunit, only GluN2B responses should be affected. This is likely to have important functional consequences given the predominant role of GluN2B-containing receptors (over GluN2A-containing receptors) in triggering neuronal death. In our revised manuscript, these aspects are discussed (p15, end of 1 st paragraph and p16 lines 10 to 21).
1-There have been several studies in the past looking at the interactions of various polyamines with the so-called "polyamine-potentiating site" of NMDA receptors. These studies concluded that the polyamine spermidine, four methylene groups shorter than spermine, produces effects qualitatively similar to those of spermine while arcaine, cadaverine or putrescine produces no or little potentiating effect (see, for instance, Williams et al., Mol. Pharmacol., 1989; Araneda et al., Neurosci Lett, 1993; Benveniste and Mayer, J Physiol., 1993; Gallagher et al., JBC 1997; Masuko et al., JPET, 1999) . From these studies, it appears that charge matters more than chain length. Indeed, arcaine, cadaverine and putrescine have only two ionizable groups while spermidine (length comparable to arcaine) has three and spermine, which produces the largest effects, four. The importance of the charge fits well with our model showing that "electrostatics is a major driving force in controlling the A/D equilibrium" (see Discussion p14, line 7). To be more precise and correct, when presenting our model (Figure 7) , we now specifically mention spermine and spermidine in the text rather than just polyamines in general (see p14, line 17). Figure 7c has also been modified by replacing the mention "polyamine" by "spermine" and the legend modified accordingly.
2-As discussed above in our reply to point 5 of referee 2, the interaction between spermine and the negative allosteric modulators zinc and ifenprodil has been previously studied by Traynelis and coll. (J. Neurosci, 1998) and in the work of Kew and Kemp (J Physiol, 1998) . There is a negative allosteric (non-competitive) interaction between these modulators such that spermine alleviates zinc (or ifenprodil) inhibition. Our current work now provides a mechanistic explanation for these functional effects. In the revised manuscript, we discuss in depth these aspects in the context of our mechanistic scheme for bidirectional allosteric modulation of NMDA receptors by the NTDs (Discussion section p14, last paragraph).
3-Indeed, the GluN2B NTD-ABD linker plays an important role in the action of spermine. Our GluN2A/GluN2B chimeric constructs (Figure 2) show that a near complete transfer of spermine sensitivity to (spermine-insensitive) GluN2A receptors is achieved only when the linker is transferred together with the preceding NTD. Interestingly, we had obtained a similar result in our previous study on the influence of the N-terminal region of NMDA receptor on intrinsic channel activity (see Gielen et al., Nature, 2009) . Moreover, for the present revision, we have performed an additional experiment -characterization of the spermine sensitivity of the GluN2B-2A(L) chimerathat clearly shows that the GluN2B linker is required for the full spermine effect (the chimera shows a decreased maximal level of spermine potentiation while the apparent spermine affinity is close to that of wt GluN2B receptors; see full DR curve in the new Supplementary Figure 1b and reply to point 1 of referee 2). We interpret these results as evidence of the critical role of the GluN2B linker in transducing spermine binding to downstream gating elements ultimately leading to changes in channel activity. We highlight this point in the revised manuscript (see end of p6 in Results section). That said, we currently have no clear molecular explanation, in terms of structural determinants, to account for the role of the linker in spermine potentiation (nor in the control of channel Po). The crystal structure of the AMPA GluA2 structure obtained by Gouaux and coll in 2009 clearly shows that the NTD-ABD linkers are optimally located to transduce conformational changes that could occur at the level of the NTDs to the downstream gating machinery. Moreover, the structure shows that the linker can adopt either an extended or a loose conformation, depending on the position of the subunit in the receptor complex (internal vs external subunits). Interestingly, in NMDA receptors, the linkers are highly charged and we suspect that electrostatic interactions are in play in the linker's action on receptor function. Obviously much remains to be learned on these linkers and that is the reason why we have recently decided to initiate a new project specifically designed to study the NTD-ABD linkers in NMDA receptors. In particular, we have launched a series of constructs in which both GluN1 and GluN2B linkers are shortened or lengthened. We hope that these and other experiments will help us understand how the NTD-ABD linkers influence receptor gating and modulation.
4-We have not constructed this chimera. However, the results presented in Figure 3d show that the chimera GluN2A-2B(175-227) confers spermine sensitivity while the shorter chimera GluN2A-2B(175-204) does not. It is thus likely that the chimera which is even shorter won't allow transfer of spermine sensitivity.
5-We have reworded this sentence to make the statement less definitive and strong. It now reads "second, allosteric modulators are generally thought to be effective at concentrations lower than those used for ligands that compete with the natural agonist".
2nd Editorial Decision 24 May 2011
Thank you for sending us your revised manuscript. Our original referees 1 and 2 have now seen it again, and you will be pleased to learn that in their view you have addressed their criticisms in a satisfactory manner, and that the paper will therefore be publishable in The EMBO Journal.
Before this will happen, however, I was wondering whether you would like to consider addressing the minor issues suggested by the referees (see below). Furthermore, there are two editorial issues that need further attention. First, I would like to ask you to include an author contribution section into the main body of the manuscript text. Second, please indicate the number of independent repeats in the figure legends of figures 4d, S5, S6.
Please let us have a suitably amended manuscript as soon as possible. I will then formally accept the manuscript.
Thank you very much again for considering our journal for publication of your work.
Yours sincerely,
Editor
The EMBO Journal
REFEREE REPORTS
Referee #1 (Remarks to the Author):
The revised manuscript addresses the concerns raised in my prior review. This is an important and timely study that comes close to solving a decade old problem in molecular neuroscience. I remain skeptical that the model proposed in Figure 7 is correct, but would not deny the authors the chance to show this, since its consistent with a lot of data from several groups, and the final word will come only from additional structural analysis, which the authors concede.
There are several minor issues which need attention.
Page 3 paragraph 1 line 9: should read of the inactive or active states.
Page 3 paragraph 1 lines 13-14: As noted by another reviewer I too am unaware of any evidence for the general idea that the allosteric ligands act at lower concentrations than competitive ligands. Its certainly not the case here, where mM concentration of polyamines are required for maximal effect. I suggest deleting the text.
Page 3 paragraph 1 line 2 from end: much details should be much detail.
Page 6 paragraph 2 line 2 from end: I'm not convinced that this interpretation of a transducing action is correct. It is also possible that the 'linker' forms part of the binding site for polyamines, but that in isolation it is too weak, or too distant from the dimer effect to create a measurable change.
Page 8 line 9 from end change to induced comparable maximal potentiation Page 9 line 1 should read spermine binds at an interface Page 9 paragraph 1: It would be appropriate to cite the recent cross linking studies of Lee & Gouaux who also find evidence for ATD heterodimers (PLoS One 6:e19180)
Referee #2 (Remarks to the Author):
The revised version of Mony et al has improved further, the authors have addressed the comments raised.
The statement on page 7, stating that the AMPA receptor lower lobe interface 'is mostly hydrophobic' is not correct; it's 'partly hydrophobic' as polar residues are interspersed between hydrophobic side chains in GluA2. GluA3 features a positive electrostatic potential in this region.
2nd Revision -authors' response 25 May 2011
Please find enclosed the final revisions of our manuscript entitled "Binding-site and mechanism of positive allosteric modulation of GluN2B NMDA receptors by polyamines" by Mony and collaborators. As requested, we have included an author contribution section into the main body of the manuscript text (see p 17) and added the n values in the figure legends of figures 4d, S5 and S6. We have also taken into account most of the referees' remarks (minor wording modifications).
